GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Map2k2 | decreases phosphorylation | EXP | | 6480464 | CTD | sorafenib results in decreased phosphorylation of MAP2K2 protein | PMID:17341847 | Map2k2 | decreases phosphorylation | ISO | MAP2K2 (Homo sapiens) | 6480464 | CTD | sorafenib results in decreased phosphorylation of MAP2K2 protein | PMID:17341847 PMID:18200035 | Map2k2 | multiple interactions | ISO | MAP2K2 (Homo sapiens) | 6480464 | CTD | [sorafenib co-treated with PI103] inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K2 protein]; sorafenib inhibits the reaction [EGF protein results in increased phosphorylation of MAP2K2 protein] | PMID:21187475 | |
Go Back to source page | Continue to Ontology report |